You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AG-013736

Showing 1 - 25 of 472
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2022

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Unresectable Melanoma Trial in Pittsburgh (Nivolumab, Duvelisib)

Recruiting
  • Unresectable Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Apr 19, 2022

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +3 more
  • Avelumab
  • +7 more
  • Danville, Illinois
  • +4 more
Jul 29, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Endometriosis, Endometriosis Ovary, Endometriosis Externa Trial in Basel (Linifanib, BIBW2992, Axitinib)

Withdrawn
  • Endometriosis
  • +3 more
  • Linifanib
  • +2 more
  • Basel, Вâlе, Switzerland
    BioGene Pharmaceutical Ltd.
Oct 24, 2021

Renal Cell Cancer Trial in Japan, United Kingdom, United States (Avelumab (MSB0010718C), Axitinib (AG-013736))

Completed
Has Results
  • Renal Cell Cancer
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Scottsdale, Arizona
  • +20 more
Dec 6, 2021

Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

Completed
Has Results
  • Melanoma
  • +4 more
  • therapeutic conventional surgery
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 30, 2020

Solid Tumors Trial in Worldwide (axitinib, crizotinib)

Active, not recruiting
  • Solid Tumors
  • Orange, California
  • +33 more
Jan 30, 2021

Renal Cell Carcinoma Trial in Omaha, Cleveland, Philadelphia (Axitinib)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Omaha, Nebraska
  • +2 more
Jul 26, 2021

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Stage III Prostate Cancer, Stage IV Prostate Cancer Trial in Duarte (drug, procedure, other)

Completed
  • Stage III Prostate Cancer
  • Stage IV Prostate Cancer
  • Duarte, California
    City of Hope Medical Center
Mar 8, 2021

Kidney Tumors Trial in Worldwide (Axitinib (AG-013736), Sorafenib)

Completed
Has Results
  • Kidney Neoplasms
  • Miami, Florida
  • +124 more
Apr 9, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Non-metastatic Renal Cell Carcinoma Trial in United Kingdom (Axitinib

Completed
Has Results
  • Renal Cell Carcinoma
  • +2 more
  • Axitinib Oral Tablet
  • Chelmsford, Essex, United Kingdom
  • +6 more
Jun 9, 2021

Soft Tissue Sarcoma Trial in United Kingdom (Axitinib)

Completed
  • Soft Tissue Sarcoma
  • Aberdeen, Scotland, United Kingdom
  • +12 more
Mar 17, 2021

Hepatocellular Carcinoma Trial in Calgary, Toronto (Axitinib (AG-013736))

Completed
  • Hepatocellular Carcinoma
  • Axitinib (AG-013736)
  • Calgary, Alberta, Canada
  • +1 more
Dec 11, 2019

Tumor Metastasis Trial in Worldwide (PF-07265807, Sasanlimab, Axitinib)

Recruiting
  • Neoplasm Metastasis
  • Fayetteville, Arkansas
  • +33 more
Aug 20, 2022

Tumors Trial in Madison (AG-013736)

Completed
  • Neoplasms
  • AG-013736
  • Madison, Wisconsin
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 15, 2019

Carcinoma, Hepatocellular Trial in Japan (Avelumab (MSB0010718C), Axitinib (AG-013736))

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Nagoya, Aichi, Japan
  • +6 more
Sep 1, 2020

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab (MSB0010718C), Axitinib (AG-013736))

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Glendale, Arizona
  • +36 more
Aug 16, 2022

Carcinoma, Renal Cell Trial in Japan (AG-013736)

Completed
Has Results
  • Carcinoma, Renal Cell
  • AG-013736
  • Kashiwa, Chiba, Japan
  • +17 more
May 22, 2019